GC
EW icon

Gratus Capital’s Edwards Lifesciences EW Stock Holding History

Gratus Capital’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		$1.04M Buy
11,303
+1,407
+14% +$125K 0.04% 178
2024
Q1 		$946K Sell
9,896
-3,460
-26% -$291K 0.04% 173
2023
Q4 		$1.02M Sell
13,356
-831
-6% -$57.8K 0.06% 144
2023
Q3 		$983K Buy
14,187
+194
+1% +$15.6K 0.07% 137
2023
Q2 		$1.32M Sell
13,993
-425
-3% -$36.9K 0.09% 120
2023
Q1 		$1.19M Sell
14,418
-1,862
-11% -$146K 0.09% 116
2022
Q4 		$1.21M Sell
16,280
-112,122
-87% -$8.64M 0.1% 121
2022
Q3 		$10.6M Buy
128,402
+110,827
+631% +$10.7M 1.12% 36
2022
Q2 		$1.67M Hold
17,575
– – 0.19% 87
2022
Q1 		$2.07M Sell
17,575
-1,216
-6% -$136K 0.2% 84
2021
Q4 		$2.43M Sell
18,791
-6
-0% -$700 0.23% 77
2021
Q3 		$2.13M Hold
18,797
– – 0.23% 78
2021
Q2 		$1.95M Sell
18,797
-24,000
-56% -$2.26M 0.22% 81
2021
Q1 		$3.58M Sell
42,797
-4,800
-10% -$406K 0.43% 75
2020
Q4 		$4.34M Sell
47,597
-2,893
-6% -$240K 0.58% 60
2020
Q3 		$4.03M Hold
50,490
– – 0.63% 59
2020
Q2 		$3.49M Sell
50,490
-3,126
-6% -$222K 0.59% 60
2020
Q1 		$3.37M Hold
53,616
– – 0.63% 56
2019
Q4 		$4.17M Sell
53,616
-3,300
-6% -$258K 0.63% 54
2019
Q3 		$4.17M Hold
56,916
– – 0.68% 51
2019
Q2 		$3.5M Sell
56,916
-1,125
-2% -$68K 0.57% 60
2019
Q1 		$3.7M Sell
58,041
-4,383
-7% -$250K 0.62% 57
2018
Q4 		$3.19M Sell
62,424
-2,202
-3% -$111K 0.65% 56
2018
Q3 		$3.75M Sell
64,626
-996
-2% -$48.7K 0.51% 52
2018
Q2 		$3.18M Hold
65,622
– – 0.47% 57
2018
Q1 		$3.05M Hold
65,622
– – 0.44% 61
2017
Q4 		$2.46M Hold
65,622
– – 0.32% 75
2017
Q3 		$2.39M Hold
65,622
– – 0.33% 74
2017
Q2 		$2.59M Buy
+65,622
New +$2.4M 0.37% 69
2017
Q1 		– Sell
-66,042
Closed -$2.06M – 179
2016
Q4 		$2.06M Buy
+66,042
New +$2.14M 0.31% 75

Other funds holding EW

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Gratus Capital's EW Position: Q2 2024 in Review

Gratus Capital increased its Edwards Lifesciences (EW) stake by 14% in Q2 2024, buying an estimated $125K and bringing the position to 11,303 shares worth $1.04M. The position accounts for 0.04% of the portfolio, ranked #178.

Gratus Capital first reported a position in EW in Q4 2016 and has held it in 30 quarters since. The position peaked at $10.6M in Q3 2022. 1,295 funds tracked by Wall St. Rank hold EW as of Q2 2024.

  • Gratus Capital held 11,303 shares of Edwards Lifesciences worth $1.04M as of Q2 2024.
  • Gratus Capital bought 1,407 Edwards Lifesciences shares in Q2 2024, an estimated $125K.
  • Edwards Lifesciences made up 0.04% of Gratus Capital's portfolio in Q2 2024, its #178 holding.
  • Gratus Capital first reported a position in Edwards Lifesciences in Q4 2016 and has held it in 30 quarters since.
  • Gratus Capital's Edwards Lifesciences position peaked at $10.6M in Q3 2022.
  • 1,295 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2024.

Based on Gratus Capital's 13F filing for Q2 2024, filed 25 Jul 2024.